Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Martinez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Vaccination against neoantigens induced in cross-priming cDC1 in vivoEmily S Clark, Ana Paula Benaduce, Wasif N Khan, et al.
Immunotherapy Advances|June 27, 2025
GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditionsRobert Page, Olivier Martinez, Daniel Larcombe-Young, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 5, 2017
PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 ReceptorsAudrey Castaing-Berthou, Nicole Malet, Claudia Radojkovic, et al.
Nature Communications|November 23, 2021
Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunityBrett Schrand, Emily Clark, Agata Levay, et al.
Nature Communications|August 24, 2018
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunityBrett Schrand, Emily Clark, Agata Levay, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Cell Reports. Medicine|January 14, 2022
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancerRichard E Beatson, Ana C Parente-Pereira, Leena Halim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Vaccination against neoantigens induced in cross-priming cDC1 in vivoEmily S Clark, Ana Paula Benaduce, Wasif N Khan, et al.
Immunotherapy Advances|June 27, 2025
GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditionsRobert Page, Olivier Martinez, Daniel Larcombe-Young, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 5, 2017
PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 ReceptorsAudrey Castaing-Berthou, Nicole Malet, Claudia Radojkovic, et al.
Nature Communications|November 23, 2021
Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunityBrett Schrand, Emily Clark, Agata Levay, et al.
Nature Communications|August 24, 2018
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunityBrett Schrand, Emily Clark, Agata Levay, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Cell Reports. Medicine|January 14, 2022
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancerRichard E Beatson, Ana C Parente-Pereira, Leena Halim, et al.
Pageof 1